Zoetis (ZTS) Non-Current Assets (2012 - 2026)

Zoetis' (ZTS) quarterly Non-Current Assets came in at $8.7 billion in Q1 2026, up 5.58% year-on-year from $8.2 billion in Q1 2025, and little changed on a QoQ basis from $8.7 billion in Q4 2025.

Zoetis (ZTS) Non-Current Assets (2012 - 2026) Analysis & Trends

Zoetis (ZTS) has 15 years of Non-Current Assets data on file, last reported at $8.7 billion in Q1 2026.

  • On a quarterly basis, Non-Current Assets rose 5.58% year-over-year to $8.7 billion in Q1 2026; TTM through Mar 2026 was $34.5 billion, a 6.33% increase from a year earlier, with the FY2025 full-year figure at $8.7 billion, up 6.12% from the prior year.
  • Non-Current Assets for Q1 2026 stood at $8.7 billion, roughly flat from $8.7 billion in the prior quarter.
  • Over the last five years, Non-Current Assets for ZTS reached as high as $8.7 billion in Q4 2025 and fell as low as $7.0 billion in Q1 2022.
  • Historically, Non-Current Assets has averaged $7.9 billion across 5 years, with a median of $8.0 billion in 2024.
  • Across the five-year window, Non-Current Assets rose 0.3% in 2022 and gained 10.68% in 2023, its largest moves.
  • Year by year, Non-Current Assets stood at $7.4 billion in 2022, then increased by 7.06% to $7.9 billion in 2023, then gained by 3.41% to $8.2 billion in 2024, then gained by 6.12% to $8.7 billion in 2025, then retreated by 0.42% to $8.7 billion in 2026.
  • Per Business Quant data, the three most recent Non-Current Assets figures were $8.7 billion in Q1 2026, $8.7 billion in Q4 2025, and $8.6 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 36.78 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 26.33 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 8.68 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 79.20 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 3.84 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 15.70 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 25.92 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 2.47 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 9.64 Bn
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn 670.50 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 8.68 Bn
Dec 31, 2025 8.72 Bn
Sep 30, 2025 8.58 Bn
Jun 30, 2025 8.56 Bn
Mar 31, 2025 8.22 Bn
Dec 31, 2024 8.21 Bn
Sep 30, 2024 8.08 Bn
Jun 30, 2024 7.96 Bn
Mar 31, 2024 7.99 Bn
Dec 31, 2023 7.94 Bn
Sep 30, 2023 7.88 Bn
Jun 30, 2023 7.57 Bn
Mar 31, 2023 7.49 Bn
Dec 31, 2022 7.42 Bn
Sep 30, 2022 7.12 Bn
Jun 30, 2022 7.12 Bn
Mar 31, 2022 7.02 Bn
Dec 31, 2021 6.97 Bn
Sep 30, 2021 7.02 Bn
Jun 30, 2021 7.02 Bn